Breast Epigenetic Plasticity and Evolution Group
Professor Magnani's group is researching methods to disrupt the adaptive capabilities of Oestrogen Receptor Positive Breast Cancer, aiming to inhibit its evolution and thereby prevent relapse in patients receiving endocrine therapies.